Read the highlights from our February 2020 issue in the slideshow below.
Read the highlights from our February 2020 issue in this slideshow.
The February 2020 issue of Dermatology Times
GO TO THE STORY: We spoke with Andrew F. Alexis, M.D., MPH about his more than 15 years of work to close the gaps in the care of dermatology patients with skin of color.
GO TO THE STORY: David J. Goldberg, M.D., discusses the nuances of physician negligence.
GO TO THE STORY: Carol Soutor, M.D., believes more dermatologist should consider recommending mind-body therapies for patient with skin disorders.
GO TO THE STORY: A recent study suggests that topical botanicals may improve mild-to-moderate AD symptoms in children.
GO TO THE STORY: Researchers recently undertook an epidemiologic study to investigate the prevalence of palmoplantar pustulosis and co-existing PsO.
GO TO THE STORY: Treating all acne early with topical retinoid and an antibiotic can help patients avoid scarring and its psychosocial consequences, expert say.
GO TO THE STORY: Rosacea is common and affects up to 10% of the population; but its true prevalence is unknown because the condition is commonly underdiagnosed.
GO TO THE STORY: Gene expression profile (GEP) testing outcomes have positively impacted the management decision-making process for cutaneous SCC, says a recent study.
GO TO THE STORY: DAXI, a novel neuromodulator, was investigated as a treatment for moderate-to-severe glabellar lines in three phase 3 clinical trials.
